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a  b  s  t  r  a  c  t
Primer  and  probe  sequence  designs  are  among  the  most  critical  input  factors  in real-time  polymerase
chain  reaction  (PCR)  assay  optimization.  In this  study,  we  present  the  use of  statistical  design  of experi-
ments  (DOE)  approach  as  a general  guideline  for probe  optimization  and  more  speciﬁcally  focus  on  design
optimization  of label-free  hydrolysis  probes  that  are  designated  as  mediator  probes  (MPs), which  are  used
in  reverse  transcription  MP  PCR  (RT-MP  PCR).  The  effect  of three  input factors  on  assay  performance  was
investigated:  distance  between  primer  and  mediator  probe  cleavage  site;  dimer  stability  of MP  and  target
sequence  (inﬂuenza  B virus);  and  dimer  stability  of  the  mediator  and  universal  reporter  (UR).  The  results
indicated  that  the latter  dimer  stability  had  the  greatest  inﬂuence  on  assay  performance,  with  RT-MP
PCR  efﬁciency  increased  by  up to 10%  with changes  to this  input  factor.  With an  optimal  design  conﬁgu-niversal reporter
eal-time PCR
CR optimization
ration,  a detection  limit  of  3–14  target  copies/10  l reaction  could  be  achieved.  This  improved  detection
limit  was  conﬁrmed  for another  UR design  and  for  a second  target  sequence,  human  metapneumovirus,
with  7–11  copies/10  l reaction  detected  in an optimum  case.  The DOE  approach  for  improving  oligonu-
cleotide  designs  for  real-time  PCR not  only  produces  excellent  results  but may  also  reduce  the  number
of  experiments  that  need  to be  performed,  thus  reducing  costs  and  experimental  times.
©  2015  The  Authors.  Published  by  Elsevier  GmbH.  This  is an  open  access  article  under  the CCThese deﬁnitions of the following terms have been taken from
he speciﬁed references
Analytical performance characteristics (of real-time PCR):
xpress the potential power of the analytical method (the real-time
CR assay) [1,2]. Here we employ:
 Selectivity (also expressed as speciﬁcity): the ability of a mea-
surement procedure to solely assess the measurand [3].
 Accuracy: closeness of agreement between a test result and the
accepted reference value [4].
 Precision: degree of agreement between independent test
results obtained under stipulated conditions [4].
 Limit of detection: lowest amount of analyte in a sample that
can be detected but not quantiﬁed as an exact value [5].
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epartment of Microsystems Engineering, University of Freiburg, Georges-Koehler-
llee 103, 79110 Freiburg, Germany.
E-mail address: Simon.Wadle@Hahn-Schickard.de (S. Wadle).
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ttp://dx.doi.org/10.1016/j.bdq.2015.12.002
214-7535/© 2015 The Authors. Published by Elsevier GmbH. This is an open access artic
.0/).BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
© Linear dynamic range: quantity of the measurand to be deter-
mined by a linear calibration curve [6].
© Real-time PCR efﬁciency: measure of the power of product for-
mation in one particular PCR cycle [6].
Statistical design of experiments (DOE): aims to optimize a
method with minimized costs and time by lowering the extent
of the experiments to a statistically relevant level [7]. The follow-
ing are important terms from the DOE approach used within this
article:
© Target value: single or a combination of values, such as dif-
ferent performance characteristics, that can be measured and
that are representative of the performance of the method to be
optimized [7].
© Input factor: parameter that can systematically vary in magni-
tude (=input factor level) during a DOE study to determine its
effect on one or more target values [7].
© Screening: experimental design that enables the evaluation of
whether one input factor, a set of input factors, or a certain input
le under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
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factor combination effectively alters one or several target values
[7].
 Full factorial design: a design of experiment in which for each
input factor and input factor combination, all input factor levels
are present [7].
Gibbs free energy (G): expresses the spontaneity of a prod-
ct formation out of reactants at a given temperature and reactant
oncentrations [8]. Here negative values indicate spontaneous for-
ation of a dimer of two different oligonucleotides with a partial
everse complementary. The lower the G  the higher the stability
f the dimer.
. Introduction
Real-time polymerase chain reaction (PCR) has become the gold
tandard for detecting nucleic acids because of its robustness, low
nalytical detection limits, equipment access, and ease of perfor-
ance due to the numerous publications describing experimental
etup guidelines [9–12]. The most commonly used probe-based
eal-time PCR methods are hydrolysis probes, molecular beacons,
nd scorpion primers [13], all of which are labeled with both a
uorescence reporter dye and ﬂuorescence quencher. In contrast,
he more novel detection method of mediator probe PCR (MP
CR, Fig. 2) [14–16] incorporates the use of unlabeled, sequence-
peciﬁc MPs  in conjunction with a ﬂuorogenic universal reporter
UR) oligonucleotide. Signal generation is initiated by releasing the
ediator during the ampliﬁcation of the target sequence and its
ybridization to a dual-labeled UR. The same UR can be used to
etect many different target sequences. This ﬂexibility facilitates
ost reductions, improved homogeneity in ﬂuorescence signals,
nd easier optimization of ﬂuorescence signal generation, which
s primarily determined by UR quenching and ﬂuorescence signal
mission efﬁciencies [17].
Independent of the probing method used to detect nucleic acid
arget sequences, a suitable probe design is crucial to achieve good
nalytical performance. The analytical performance characteristics
f a real-time PCR assay are referred to as “target values” through-
ut this article. These target values mainly comprise selectivity,
recision, accuracy, detection limits, linear dynamic range, and efﬁ-
iency of the real-time PCR assay [2,6,18–21]. In an experiment
esigned for probe optimization, not all of these target values can
e determined because of the cost involved and time restrictions.
owever, at a minimum, the most important target values with
espect to practical application should be identiﬁed.
Previous studies reported that the statistical design of exper-
ments (DOE) approach as described by G. Taguchi [18,22–26],
hich originated from optimization studies for engineering pro-
esses, demonstrates distinct advantages over approaches that
ptimize one factor at a time in improving PCR-based assay per-
ormance. In general, the DOE approach guides the investigator
hrough the experimental setup and data analysis, thus simplifying
he analysis of the complex interactions between the input factors.
urthermore, the number of experiments required for optimiza-
ion can be reduced because of the maximization of information
n the effects of certain input factors on the basis of the tests per-
ormed [7,27]. In addition, the DOE approach can improve input
actor differentiation between those that inﬂuence local target
alue optimum and those that lead to a more general target value
ptimization.
Taguchi-based optimization has been previously used to
mprove PCR target values by modifying the input factors of the
rimer, probe, and magnesium chloride concentrations or chang-
ng the temperature proﬁle [28–30]. To the best of our knowledge,
here are no reports regarding DOE application to real-time PCRFig. 1. DOE-based process optimization. The examples (bold text) were developed
on  the basis of the presented optimization of RT-MP PCR.
probe sequence optimization, despite this input factor exerting a
substantial inﬂuence on real-time PCR performance [8,31,32].
With MP  PCR, the target value depends on MP  sequence inter-
action with both the target sequence itself and UR. Other relevant
input factors include the polymerase’s MP  cleavage efﬁciency, or
the UR’s signal generation efﬁciency. The latter depends on the
polymerase-mediated extension of the released mediator and the
ratio between the initial quenching efﬁciency and ﬂuorescence
signal emission following the introduction of spatial separation
between the ﬂuorophore and quencher [17]. In this study, we ﬁrst
used DOE to determine the dominant input factors that had the
greatest effect on MP-PCR target values. Second, we optimized RT-
MP  PCR performance and particularly the analytical detection limit
by optimizing the level of each determined input factor. Using RT-
MP PCR, the detection limit must be at a minimum, i.e., as low
as with hydrolysis probes, which are the gold standard references
for real-time PCR. For this DOE-based optimization, we selected
two clinically relevant targets that cause acute respiratory tract
infections, namely inﬂuenza B virus (InfB) and human metapneu-
movirus (hMPV) [17]. In this manner, a guideline for mediator probe
sequence optimization has been established that can be extended
to other probe formats. This DOE approach is outlined in Fig. 1 and
described in detail below.
2. Materials and methods
This DOE-based input factor screening study for RT-MP PCR opti-
mization followed the four steps described in Fig. 1. The following
section describes the principle approach and actual experiments
performed.
2.1. Deﬁnition of optimization goalSelected RT-MP PCRs were used to detect InfB and hMPV viral
RNA. In clinical studies the viral load of these targets ranged
between 103and108 RNA copies per ml  sample [33]. Therefore, the
optimization goal was  deﬁned as follows: The assay must enable
S. Wadle et al. / Biomolecular Detection and Quantiﬁcation 7 (2016) 1–8 3
Fig. 2. Mediator probe PCR cycle with mediator probe sequence interactions (dotted ovals). The mediator probe (MP) and universal reporter (UR) with corresponding
sequence modiﬁcations are presented in the box. The different steps of MP  PCR are given below (1–5). In the presence of its complementary target DNA sequence, MP anneals
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4o  the sequence (1) and is subsequently cleaved during primer extension (2 + 3). Th
ubsequent extension of the mediator at UR, the ﬂuorophore and quencher are sepa
e.g.,  initial PCR cycles) of target DNA is present, the uncleaved mediator probe hyb
he detection of 10–100 RNA copies per l RNA input volume per
eaction.
.2. Selection of performance characteristics and target value
To determine the lower limit of detection, many replicates need
o be analyzed per concentration (nine in this study). Comparing all
ossible MP  designs at this level of replication would not be eco-
omically feasible. Other performance characteristics that at least
nﬂuence the limit of detection were, thus, selected and measured
sing fewer replicates as previously proposed [34]. A target value
as calculated (Eq. (1)) from data using an RNA dilution series (InfB)
o determine as many performance characteristics as possible: PCR
fﬁciency (calculated from the standard curve), quantitative corre-
ation between RNA input and output concentrations (R2 from the
tandard curve), mean signal increase over the ﬂuorescence back-
round signal as a measure for detecting sensitivity, and Cq value
f reactions with 104 target RNA copies/reaction, which is a mea-
ure for the reaction velocity. The abstracted target value was, thus,
alculated as follows:
arget value = a × R
2 + b × PCR efﬁciency + c × signal increase
d × Cq value at 104 copies/reaction
(1)
Coefﬁcients a–d were used to balance the performance charac-
eristic value inﬂuence on the target value. Coefﬁcient values were
etermined according to the mean values of the four different per-
ormance characteristics for the nine different MPs  (refer to Section
).iator is set free to hybridize to the UR mediator hybridization site (4). Through the
 and a ﬂuorescence signal is generated (5). If no target DNA or an abundant amount
s to UR but is not extended. (Modiﬁed from [14]).
2.3. Selection of input factors and factor levels for screening
It is necessary to select an appropriate number of input factors
to evaluate their real effectiveness on the target value. All possible
input factors were collected on the basis of the MP interactions
present during an MP  PCR cycle (Fig. 2).
These input factors were collectively assessed (Table 1) accord-
ing to the interactions illustrated in Fig. 2 using important DOE
criteria [7]. Most input factors [(D)–(G)] could be excluded from
the screening study because of poor variability, i.e., no sufﬁciently
different MP  designs could be created on the basis of these input fac-
tors. The qualitative assumption of input factor effectiveness was
based on different previous (RT-)MP PCR assays. In these previous
experiments, the effects of input factors were not systematically
investigated, as was the case in this study. However, input fac-
tors (A)–(D) reproducibly demonstrated a strong effect in different
assays and different experimental conditions, e.g., a strong effect
on PCR efﬁciency.
Three input factors were ﬁnally selected: G of the MP-target
heterodimer, G  of the mediator-UR heterodimer, and distance
of the sense primer 3′-terminal to the MP-target heterodimer
cleavage site. Next, two levels were established for each fac-
tor that spanned an appropriate range according to the pre-test
results. This resulted in 23 = 8 MP  designs. In addition to these
eight designs, a ninth design was selected that incorporated all
input factors at a central level. The latter design enabled screen-
ing for non-linear relationships between factor levels and the
target value. Moreover, this MP  design was  used for data calibra-
tion between several RT-PCR runs conducted during the screening
experiment.
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Table  1
Assessment of input factors. Qualitative assessment ranged from +++ (very good) to + (poor). The input factors (A)–(C) were ultimately selected (bold text).
Input factor Assumed
effectiveness
Independent
variability
Variability at
representative factor levels
Quantitative
variability
(A) G of the MP-target heterodimer +++ + +++ +++
(B)  G of the mediator-UR heterodimer +++ + +++ +++
(C)  Distance between primer and MP cleavage site +++ + +++ +++
(D)  Mediator length +++ + ++ +++
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. Materials
Concentration standards of RNA target sequences for use with
nput factor screening and conﬁrmation studies comprised in vitro
ranscripts from synthetic DNA sequences encoding InfB (hemag-
lutinin (HA) gene; transcript length: 170 nt) and hMPV (fusion
rotein gene; transcript length: 70 nt). RNA concentration stan-
ards were provided by the University Medical Center Göttingen
irology Department and were prepared as previously described
35]. The transcript sequences are listed as supplementary infor-
ation. Both InfB and hMPV RNA concentration standards were
iluted in 100 g/ml baker’s yeast tRNA, which served as a blocking
gent (Roche, Germany, cat. no. 10109495001).
All primers, MP  and UR sequence designs, and reference hydrol-
sis probe (HP) sequence designs are listed in Table 2. All sequences
ere designed using VisualOMPTM (DNA Software®, USA, Version
.8.42.0) [8,11,36].
The Qiagen QuantiTect Multiplex RT-PCR NR Kit (Qiagen,
ermany, cat. no. 204843) was used for one-step reverse
ranscription–ampliﬁcation reactions. Each 10 l reaction was per-
ormed with ﬁnal concentrations of primers at 300 nM,  MPs  or HPs
t 150 nM,  and UR at 100 nM.
.1. Setup and analysis of input factor screening
All nine InfB MP  designs (Table 2 A1–A9) were tested in the
mpliﬁcation reactions with different InfB target RNA concentra-
ions spanning 105–102 InfB copies/10 l reaction. All reactions
ere performed in quadruplicate. For each RT-MP PCR run, four
0 l reactions for ampliﬁcation and detection of InfB target RNA
104 copies/10 l reaction) using MP  InfB A5 were used as an
nter-run calibrator and were co-analyzed with all other InfB ampli-
cations. The RT-real-time MP  PCR were performed in a Rotor-Gene
 (Qiagen, Hilden, Germany) using the following reaction protocol:
0 min  at 50 ◦C (reverse transcription), 15 min  at 95 ◦C (hot start),
0 × (10 s at 94 ◦C and 45 s at 60 ◦C). For ﬂuorescence signal gen-
ration, UR A was used in all reactions. Fluorescence signals were
cquired at the end of each 60 ◦C-cycling step with signal acquisi-
ion using the Cy5-readout gain for UR and the FAM-readout gain
or InfB HP and hMPV HP (refer to input factor conﬁrmation study).
For data analysis, the maximum ﬂuorescence signal achieved
uring data acquisition was divided by the mean of the ﬂuores-
ence background signal during cycles 3–10 for each test at 102
opies/reaction. For establishing the other target values, the Cq
alues for all setups were determined using the Rotor-Gene Q
nalysis software Q 2.1.0.9 with slope correction for normalized
uorescence data and Cq value determination using a ﬂuorescence
hreshold set to 0.02, which was in the exponential phase of the
igmoidal ﬂuorescence curves for all setups. The Cq values for the
eparated experimental runs (Cqi) were normalized according to
he mean of the Cq values of the inter-run calibrator (four technical
eplicates) during the speciﬁc run [Cq(calibrator run)] and in all runs+ +
+ +++
+ +
[Cq(calibrator all runs)] using the equation:
Cq(normalized) = Cqi −
1
no.techn.repl.calibrator
no.techn.repl.calibrator∑
i=1
Ccalibrator runqi +
1
no.runs
no.runs∑
i=1
Ccalibrator all runsqi (2)
Standard curves were generated using normalized Cq values as
an input into the Origin 9.0 software (OriginLab Coorp., USA). Using
the standard curve, the efﬁciency of each RT-real-time MP  PCR and
the target copy number of each test were calculated. The back-
calculated copy numbers were plotted against the theoretical copy
number input and the R2 value for this correlation was determined.
Mean values for the four technical replicates were determined
for all four values to establish one discrete target value per MP
design. JMP® 8.0.1 software (SAS Institute Inc., USA) was  used for
the experimental setup design and statistical analysis. A full fac-
torial screening design was  selected to cover all combinations of
input factor levels. This experimental setup permits the analysis of
signiﬁcant effects for single input factors and programmed factor
combinations on the target value. In addition, one center point was
added to the experimental design to verify whether these input fac-
tors affect the target value in a linear or non-linear manner. Next,
the statistical signiﬁcance of these effects was  analyzed using the
JMP  screening function. This function refers to Lenth’s method for
statistical analysis, where a signiﬁcance level of 95% is applied. This
means that the effect of an input factor or input factor combination
on the target value was  signiﬁcant if the analysis produced a p value
of <0.05.
3.2. Setup and analysis of input factor conﬁrmation
This test was  performed to assess the appropriateness of the
DOE-based approach for MP  design optimization. The input factor
with the largest effect on the target value was selected according to
the results of the screening study (refer to input factor with highest
value in Fig. 4). For this screening, two  factor levels, one result-
ing in relatively low target value magnitudes (MP  InfB A2, Table 2)
and one resulting in higher magnitudes (MP  InfB A7, Table 2) were
used for MP  design. The inﬂuence of this input factor on the lower
limit of detection (optimization goal) was tested for both InfB and
hMPV detections. Two different UR designs (A and B, Table 2) were
used for detecting both the targets. InfB was  diluted to the ﬁnal
concentrations of 150, 50, 17, 6, 2, and 0.6 copies/10 l reaction,
while hMPV was diluted to 150, 75, 38, 19, 9, and 5 copies/10 l
reaction. All setups were performed in nine technical replicates. In
addition, nine NTCs were analyzed for each setup. RT-real-time MP
PCR was performed as previously described. Sample ampliﬁcation
was considered positive if the following conditions were met: 1)
a sigmoidal curve shape, 2) the normalized ﬂuorescence signal in
the corresponding sample (cycles, 40–50) was  of >10-fold greater
than the standard deviation of the ﬂuorescence signal from nucleic
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Table 2
Oligonucleotide sequences (supplier: biomers.net).
Oligonucleotide or target name Description Sequence (5′–3′) Probe input factor and value
Factor A/kcal × mol−1 Factor B/kcal × mol−1 Factor C/bp
Universal reporter A UR Aa Q2-CACGCG◦A◦A◦GATGAGATCGCG(dT-Cy5)GTGTTGGTCGTAGAGCCCAGAACGAT-C3
Universal reporter B UR Ba Q2-CACCGG ◦C◦T◦AAGACGCGCCGG(dT-Cy5)GTGTTGCACCTGGGACATCGACTAT-C3
Inﬂuenza B virus (InfB)
HA gene (amplicon
length 160 bp)
Forward primer (Fw InfB) GGATTAAATAAAAGCAAGCCTTAC
Reverse primer (Rv InfB) CAGCAATAGCTCCGAAGAAAC
Hydrolysis probe Aa (HP InfB A)c 6F-CACCCATATTGGGCAATTTCCTATGGC-Q1 −18.0
Hydrolysis probe Ba (HP InfB B) 6F-CCCATATTGGGCAATTTCCTATGGC-Q1 −15.5
Mediator probeb A1 (MP  InfB A1) TCGTTCTGGGCTCTACGACC|AGGAGGCCTATATTTGGTTCCATTGG-PH −16.9 −13.9 21
Mediator probeb A2 (MP  InfB A2) TCGTTCTGGGCTCTACGACC|ACCCATATTGGGCAATTTCCTATGGC-PH −17.5 −14.0 67
Mediator probeb A3 (MP  InfB A3) TCGTTCTGGGCTCTACGACC|AGGAGGCCTATATTTGGTTCCA-PH −13.9 −13.9 21
Mediator probeb A4 (MP  InfB A4) TCGTTCTGGGCTCTACGACC|ACCCATATTGGGCAATTTCCTAT-PH −13.8 −14.0 67
Mediator probeb A5 (MP  InfB A5) ATCGTTCTGGGCTCTACGAC|ATTGGCAAGCTTCAAAGGTGTTT-PH −15.2 −13.1 37
Mediator probeb A6 (MP  InfB A6) TTCTGGGCTCTACGACC|AGGAGGCCTATATTTGGTTCCATTGG-PH −16.9 −11.3 21
Mediator probeb A7 (MP  InfB A7) TTCTGGGCTCTACGACC|ACCCATATTGGGCAATTTCCTATGGC-PH −17.5 −11.3 67
Mediator probeb A8 (MP  InfB A8) TTCTGGGCTCTACGACC|AGGAGGCCTATATTTGGTTCCA-PH −13.9 −11.3 21
Mediator probeb A9 (MP  InfB A9) TTCTGGGCTCTACGACC|ACCCATATTGGGCAATTTCCTAT-PH −13.8 −11.3 67
Mediator probeb B1 (MP  InfB B1) TCGATGTCCCAGGTGC|CCATATTGGGCAATTTCCTATGGC-PH −15.9 −11.0 70
Mediator probeb B2 (MP  InfB B2) ATAGTCGATGTCCCAGGTGC|CCATATTGGGCAATTTCCTATGGC-PH −15.9 −13.1 70
Forward primer (Fw hMPV) GCTTCAGTCAATTCAACAGAAG
Reverse primer (Rv hMPV) TGGTGTTATYCCRGCATTGTCTG
Hydrolysis probea (HP hMPV) 6F-CTAAATGTTGTGCGGCARTTTTCAG-Q1 −16.5
Human
Metapneumovirus F
gene (amplicon length
70 bp)
Mediator probeb A1 (MP  hMPV A1) TTCTGGGCTCTACGACC|TAAATGTTGTGCGGCARTTTTCAG-PH −15.0 −11.9 2
Mediator probeb A2 (MP  hMPV A2) TCGTTCTGGGCTCTACGACC|TAAATGTTGTGCGGCARTTTTCAG-PH −15.9 −13.2 2
Mediator probeb B1 (MP  hMPV A1) TCGATGTCCCAGGTGC|TAAATGTTGTGCGGCARTTTTCAG-PH −16.1 −11.0 2
Mediator probeb B2 (MP  hMPV A2) ATAGTCGATGTCCCAGGTGC|TAAATGTTGTGCGGCARTTTTCAG-PH −16.1 −13.1 2
a “◦” = phosphorothioate, underlining indicates stem, text in italics and bold indicates a mediator hybridization site; 6F = 6-Carboxyﬂuoresceine; Cy5 = Cyanine 5; Q1 = BHQ-1; Q2 = BHQ-2; C3 = C3-Spacer; R = A or G; Y = C or T.
b Text in italics and bold indicates a mediator region, underlining indicates a target-speciﬁc probe region; PH = phosphate moiety, a dashed vertical line indicates an MP cleavage site.
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Fig. 3. Screening results. Orthogonal view of MP  input factors and target values.
Three MP  input factors with two factor levels each were screened for potential inﬂu-
ence  on the target values. Low numbers and dark shading indicate a low magnitude
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arget value. Furthermore, a center point (A5) was  added to check for non-linear
nteractions.
cid negative samples (cycles, 5–15) [9]. The 95% conﬁdence inter-
als around the detection limit were determined using the SPSS
oftware version 19 Probit analysis (IBM, USA) [37].
. Results and discussion
.1. Input factor screening
Using a DOE-based approach, the effects of different MP  design
nput factors on a target value describing RT-MP PCR performance
ere evaluated. Different combinations of three MP  design input
actors at two factor levels each were screened: (A) G  of the
P-target heterodimer; (B) G  of the mediator-UR heterodimer;
nd (C) distance of the sense primer 3′-terminal to the MP-target
eterodimer cleavage site. For calculating the target value, the
oefﬁcients included in Equation 1 were determined. The target
alue was based on four single performance characteristics. To ana-
yze these performance characteristics, all MPs  were evaluated for
ig. 4. The relative effect of all input factors and input factor level combinations on t
ultiplication sign “*”) had a signiﬁcant effect on their target values (signiﬁcance level, 95
s  dominant factor. Dist. = distance. and Quantiﬁcation 7 (2016) 1–8
detectable ampliﬁcation with the serial dilution of InfB input RNA
(102–105 copies per reaction). The single performance characteris-
tics demonstrated the following ranges of values: R2, 0.997–0.996;
PCR efﬁciency, 0.89–0.99 (i.e., 89%–99%); signal increase, 2.4–16.3;
and Cq value, 19–23. Different coefﬁcients were used for calculat-
ing the target value so that all single performance characteristics
were balanced according to the mean value for all nine individual
MP designs.
Target value
= 10.02 × R
2 + 10.53 × PCR efﬁciency + 1.07 × signal increase
0.49 × Cq value at 104 copies/reaction
(1.2)
Fig. 3 illustrates the different input factor level combinations
together with the recorded target value from Eq. (1.2.)
The results clearly revealed that MP  designs with higher levels
of input factor (B) G  of the mediator-UR heterodimer consistently
produced higher target values (brighter points) compared with
those with lower values for the same input factor. Thus, the lower
the mediator-UR heterodimer stability at a given annealing temper-
ature, the higher the RT-real-time MP  PCR performance. Because an
increase in the (B) value was  accomplished by reducing the medi-
ator sequence length at its 5′-terminal, the following disturbance
variable (input variables that can cause the controlled variables to
deviate from their respective set points) had to be taken into con-
sideration. All MPs  that achieved higher target values [MPs with
higher levels of input factor (B)] had a mediator sequence length of
only 16–18 nt compared with the 19–21 nt length for the mediator
sequences from the designs that achieved lower target values [MPs
with lower levels of input factor (B)].
Changing either (A) or (C), the two other input factors did not sig-
niﬁcantly change the target value at least if factor (B) was already
at the optimal level. When factor (C) was reduced, all target val-
ues also declined. However, this effect was only signiﬁcant in cases
that included non-optimal levels of input factor (B). Factor (A) had
the smallest impact on the target value. In contrast to (B) or (C),
changing (A) in one direction did not impact the target value. Sim-
ilar to (C), a strong effect was only found for (A) in the range of
arget values. All input factors and input factor level combinations (depicted by
%) as shown using the JMP  software analysis. G mediator-UR ht. dimer was found
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Fig. 5. Detection limits of InfB and hMPV obtained by HP and RT-MP PCRs. For RT-S. Wadle et al. / Biomolecular Det
on-optimal values for (B). Misinterpreting these locally optimal
arget values was prevented by the design of the DOE-based exper-
mental setup: i.e., input factors (A) and (C) could be identiﬁed as
nput factors that do not have the largest effect on the target value.
From the single performance characteristics that produced the
arget value (supplementary information), it is apparent that MP
ith the highest target values (MP  InfB A6, A7, and A9) demon-
trated better performance in a minimum of two out of the four
ingle performance characteristics measured as compared with the
esigns with the lowest target values (MP  InfB A1-A4).
As already derived from the data space presented in Fig. 3 the
esults of the signiﬁcance analysis demonstrated that all input fac-
ors and input factor combinations did not have a signiﬁcant effect
n the target value (Fig. 4). However, input factor (B) demonstrated
he greatest effect on target value and was, therefore, regarded as
he dominant input factor. The relatively large effect of the primer-
P distance [input factor (C)] can be explained by the large drop
n the target value using MP  design A1 and A3. In all other setups,
he dominance of the effect of factor (C) is clear for both factors (B)
nd (A).
RT-real-time MP  PCR efﬁciency was evaluated as one of the
ingle performance values leading to the target values (Fig. 3).
n summary, G  of the mediator-UR heterodimer was less than
11.29 kcal/mol (disturbance variable mediator length: 19–21 nt);
hus, the minimum PCR efﬁciency achieved (MP  design A3) was
9% ± 2%. In comparison, MP  with G  of the mediator-UR het-
rodimer was more than −11.29 kcal/mol (disturbance variable
ediator length: 15–17 nt), and the minimum efﬁciency was
5% ± 1% (MP  designs A8 & A7).
Two effects were regarded as being responsible for the supe-
ior effects of input factor (B) on the target value: the efﬁciency
f MP  cleavage increases with decreasing mediator length [38],
nd the equilibrium between MP-UR heterodimers and MP-target
equence heterodimers shifts as well.
Although it was not evaluated using sequence lengths of <20 nt,
he cleavage efﬁciency of Taq polymerases toward fork-like struc-
ures, as was present in the case of the MP-target heterodimer, was
hown as being dependent on the length of the 5′-unhibridized
ap (in MP  PCR, i.e., the length of the mediator sequence) [38]. It
s assumed that this is because of the mechanism of ﬂap process-
ng by the polymerase nuclease domain as previously described
or the ﬂap endonuclease 1, which is structurally and mechanisti-
ally related to the nuclease domain in Taq polymerases [39,40]:
rior to cleavage, the ﬂap is threaded into the enzyme’s active site.
hus, shorter ﬂaps might be threaded and cleaved with a higher
fﬁciency.
Concerning the observed inﬂuence of the equilibrium between
P-UR heterodimers and MP-target sequence heterodimers, Hol-
and et al. ﬁrst investigated the 5′-3′ nuclease activity of Taq
olymerases when different probes were used during primer
xtension [41]. The experiments proved that the probe binding
ust be favored toward primer binding to enable probe binding
efore the primer extension reaches the probe binding site.
Target values achieved using the homologous probes MP
nfB A2 (G mediator UR heterodimer = −13.95 kcal mol−1;
ediator length, 19 nt) and A7 (G mediator UR het-
rodimer = −11.33 kcal mol−1; mediator length, 16 nt) were
ompared with the corresponding target value using dual-labeled
ydrolysis probes (HP InfB A) as the gold standard of the probe
esign in real-time PCR. Therefore, the same target-speciﬁc probe
equence was  used; however, the mediator was replaced by a
uorophore and the 3′-terminal phosphate by a quencher. The
ollowing mean target values were achieved using four repli-
ates of each experiment at each RNA dilution step: MP  InfB A2:
.93 ± 0.15; MP  InfB A7: 3.85 ± 0.11; and HP InfB A: 2.22 ± 0.02.
ifferences in the target value are because of the different valuesMP  PCRs, the universal reporters A and B with different mediator hybridization
sequences oligonucleotides were used. The gray areas span the lower and upper
bounds of the detection limit estimate within a 95% conﬁdence interval.
for the single performance characteristics of Cq value for reactions
with an RNA-input concentration of 104 copies/l and because of
the signal increase measured for the reactions with an RNA-input
concentration of 102 copies/l. For both characteristics, MP  InfB
A7 signiﬁcantly performed better than both others, with MP
InfB A2 containing a longer mediator (higher G mediator UR
heterodimer) along with the hydrolysis probe HP InfB A. This
observation becomes obvious on observing the RT-real-time PCR
ﬂuorescence curves of the three different setups (Supplementary
information).
Since the variability of the efﬁciency of the reverse transcrip-
tion step was not evaluated, results are prone to an uncertainty
[42,43]. However, to account for the statistical variability of the
RT efﬁciency we  performed technical replicates (4 replicates per
RNA input concentration). As can be derived from the R2 values of
the standard curve (Supplementary information), the Cq-variation
between these replicates and thus the variability of the reverse
transcription efﬁciency is considered to be not signiﬁcant in the
case of the presented study.
4.2. Input factor conﬁrmation
The actual performance characteristic to be optimized was the
assay detection limit. This important assay performance character-
istic was selected to test the relevance of results gathered in the
input factor screening. The InfB assay detection limit using a non-
optimal MP  design (MP  InfB A2) was compared with the one that
used an optimal MP  design (MP  InfB A7) and compared with a cor-
responding hydrolysis probe. Furthermore, the InfB assay detection
was also analyzed using an alternative UR. The same analyses were
performed for the hMPV detection assay.
As shown in Fig. 5, for two  different InfB and hMPV targets using
two different URs (different mediator hybridization sequences),
the optimal MP  design according to the target value magnitude
demonstrated reduced detection limits compared with the corre-
sponding HP RT-PCR. As expected from the input factor screening,
MPs  with higher G mediator-UR heterodimer levels (MP  InfB
A7:−11.33 kcal mol−1; MP  InfB B1: −11.0 kcal mol−1; MP  hMPV
A1: −11.9 kcal mol−1; and MP  hMPV B1: −11.0 kcal mol−1) demon-
strated lower limits of detection (95% probability of detection) with
the corresponding 95% conﬁdence interval than MPs with lower
levels of this input factor (B) (MP  InfB A2: −13.95 kcal mol−1; MP
InfB B2: −13.1 kcal mol−1; MP  hMPV A2: − 13.2 kcal mol−1; and
MP hMPV B2: −13.1 kcal mol−1). Compared with corresponding
HP PCRs, detection limits achieved with MP  PCR are signiﬁcantly
reduced. This is because of the higher signal-to-noise ratio of
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[42] S. Bustin, H.S. Dhillon, S. Kirvell, C. Greenwood, M.  Parker, G.L. Shipley, T.
Nolan, Clin. Chem. 61 (2015) 202–212.
[43] S.A. Bustin, T. Nolan, J. Biomol. Tech. 15 (2004) 155–166.
[44] Altona Diagnostics, RealStar® hMPV RT-PCR Kit, http://www.altona-
diagnostics.com/realstar-mpv-rt-pcr-kit.html (last accessed: 03.2015). S. Wadle et al. / Biomolecular Det
he universal reporter with a low ﬂuorophore-quencher distance
chieved by the hairpin structure compared with the dual-labeled
Ps with larger ﬂuorophore-quencher distances, depending on the
ctual probe sequence length. The analytical detection limits of <50
opies/reaction of the improved RT-MP PCR assays demonstrated
 good agreement with commercially available assays for InfB and
MPV detection [33,44].
For the reverse transcription efﬁciency variability the same
onsiderations as demonstrated before apply for the input factor
onﬁrmation.
. Conclusion
In a DOE-based MP  design screening, three different design
nput factors were selected from a group of candidates. These
actors were tested and had a signiﬁcant effect on RT-MP PCR per-
ormance in pre-tests. We  determined that the input factor G
f the mediator-UR heterodimer has the highest effect on RT-MP
CR performance. Easy adaption of MPs  leading to improved RT-MP
CR results could thus be realized just by changing the mediator
equence length. At the same time, these mediator probes also
emonstrated superior performances in RT real-time PCR com-
ared with homologous hydrolysis probes. Thus, the DOE method
ppears to be an appropriate approach for MP  sequence opti-
ization for use with real-time PCR. Only nine MP  designs led
o maximum information for the three input factors and their
ombinatorial effects. The nine designs were screened across four
echnical replicates at each of the ﬁve different RNA input concen-
rations, resulting in 180 individual performances. In contrast, a
ne-factor-at-a-time approach would require 320 individual reac-
ions [eight designs (no center point), 16 technical replicates, ﬁve
ifferent RNA concentrations] to receive information for the effect
f an input factor on the target value at the same accuracy. Second,
here is the risk associated with a local minimum in data collection
nd assay optimization [24]. On the basis of these results, we  can,
hus, recommend DOE as a guideline for MP  sequence optimization.
owever, the DOE approach may  also be applicable to other detec-
ion formats for real-time PCR (e.g., hydrolysis probes or molecular
eacons) or to PCR primer sequence design. This approach may  be
articularly relevant with diagnostic applications in which the best
erforming primers and probes must be deﬁned for the detection
f pathogenic nucleic acid sequences.
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